ENTRY       D00583                      Drug
NAME        Thiotepa (JAN/USP/INN);
            Thioplex (TN);
            Tepadina (TN);
            Rethio (TN)
PRODUCT     TEPADINA (Amneal Pharmaceuticals LLC)
  GENERIC   THIOTEPA (Athenex Pharmaceutical Division)
            THIOTEPA (Dr.Reddy's Laboratories Inc.,)
            THIOTEPA (Dr.Reddy's Laboratories Inc.,)
            THIOTEPA (Fresenius Kabi USA)
            THIOTEPA (Gland Pharma Limited)
            THIOTEPA (Hikma Pharmaceuticals USA)
            THIOTEPA (Hikma Pharmaceuticals USA)
            THIOTEPA (Hikma Pharmaceuticals USA)
            THIOTEPA (MSN LABORATORIES PRIVATE LIMITED)
            THIOTEPA (Novadoz Pharmaceuticals LLC)
            THIOTEPA (STI Pharma LLC)
            THIOTEPA (Sagent Pharmaceuticals)
FORMULA     C6H12N3PS
EXACT_MASS  189.049
MOL_WEIGHT  189.2183
CLASS       Antineoplastic
             DG01677  Alkylating agent
              DG01723  Ethylene imine
               DG01722  Thiotepa type ethylene imine
REMARK      Same as: C07641
            Therapeutic category: 4212
            ATC code: L01AC01
            Product: D00583<JP/US>
EFFICACY    Antineoplastic, Alkylating agent
  DISEASE   Beta-Thalassemia [DS:H00228]
            Graft rejection [DS:H00083]
            Adenocarcinoma of the breast or ovary [DS:H00031 H00027]
            Papillary carcinoma of the urinary bladder [DS:H00022]
COMMENT     Ethylene imine
TARGET      DNA
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01A ALKYLATING AGENTS
                L01AC Ethylene imines
                 L01AC01 Thiotepa
                  D00583  Thiotepa (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Alkylating Agents
               Thiotepa
                D00583  Thiotepa (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               421  Alkylating agents
                4212  Ethyleneimines
                 D00583  Thiotepa (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01677  Alkylating agent
               DG01723  Ethylene imine
                DG01722  Thiotepa type ethylene imine
                 D00583  Thiotepa
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00583
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00583
DBLINKS     CAS: 52-24-4
            PubChem: 7847649
            ChEBI: 9570
            LigandBox: D00583
            NIKKAJI: J2.307H
ATOM        11
            1   P1a P    24.9258  -18.5335
            2   N1y N    26.3230  -18.5335
            3   N1y N    23.5287  -18.5277
            4   N1y N    24.9200  -17.1364
            5   S0  S    24.9200  -19.9365
            6   C1x C    27.5332  -19.2350
            7   C1x C    27.5272  -17.8320
            8   C1x C    22.3128  -17.8262
            9   C1x C    22.3185  -19.2350
            10  C1x C    25.6098  -15.9203
            11  C1x C    24.2068  -15.8680
BOND        13
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 2
            5     2   6 1
            6     2   7 1
            7     3   8 1
            8     3   9 1
            9     4  10 1
            10    4  11 1
            11    6   7 1
            12    8   9 1
            13   10  11 1
///
